Big changes are in store at medical technology company Enovis, where Chief Executive Officer Matt Trerotola has announced his intention to step down. Trerotola has run the company since 2022, and will remain in the position until his successor is named, after which he will serve as an Executive Advisor to the new CEO for one year.
Additionally, the company appointed Davide Visentin as the new president of its International Surgical business, effective March 1, 2025. Visentin, a 20-year veteran in healthcare, replaced Dr. Benjamin Reinmann, who had served in the role since January 2024.
The moves come on the heels of the launch of Enovis’ Comprehensive Medical Education Program. Announced in January, the program includes customizable learning modules spanning the entire continuum of care, from performance and mobility to surgical intervention and post-operative rehabilitation.
